Age: 42 President Since 2013
The company has Return on Asset of 8.49 % which means that on every $100 spent on asset it made $8.49 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 19.48 % implying that it generated $19.48 on every 100 dollars invested.
The company has 3.97 B in debt with debt to equity (D/E) ratio of 0.78 which is OK given its current industry classification. Becton Dickinson and Company has Current Ratio of 2.82 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
Becton price boundaries
Entity SummaryBecton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. Becton Dickinson and Company [BDX] is traded on New York Stock Exchange in USA. It is located in Becton, Dickinson and CompanyFranklin Lakes, NJ and employs 29,979 people.
Filter other executives
Becton Dickinson and CompanyUSA StockCurrency: USD - US DollarTraded on New York Stock Exchange
Fix Your Portfolios with Becton
Promote Becton and Suketu Upadhyay
Becton Dickinson and Leadership
Use alpha and beta coefficients to find investment opportunities after accounting for the riskFind Alpha
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals, sectors and familiesResearch Equities
Find insiders across different sectors to evaluate their impact on performance and growth of their entitiesResearch Insiders